These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22643654)

  • 1. Are we ready to implant left ventricular assist devices in "less sick" patients?
    Jeevanandam V
    Semin Thorac Cardiovasc Surg; 2012; 24(1):8-10. PubMed ID: 22643654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term use of a left ventricular assist device for end-stage heart failure.
    Rose EA; Gelijns AC; Moskowitz AJ; Heitjan DF; Stevenson LW; Dembitsky W; Long JW; Ascheim DD; Tierney AR; Levitan RG; Watson JT; Meier P; Ronan NS; Shapiro PA; Lazar RM; Miller LW; Gupta L; Frazier OH; Desvigne-Nickens P; Oz MC; Poirier VL;
    N Engl J Med; 2001 Nov; 345(20):1435-43. PubMed ID: 11794191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular assist devices as destination therapy: a new look at survival.
    Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of left ventricular assist devices in the treatment of class IV heart failure patients: what the non-heart failure specialist needs to know.
    Ahmed M; Aranda JM; Schofield RS; Bell JM; Reid JA; Klodell CT
    Cardiol Rev; 2013; 21(1):37-41. PubMed ID: 22643346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal change in quality of life and impact on survival after left ventricular assist device implantation.
    Grady KL; Meyer PM; Dressler D; Mattea A; Chillcott S; Loo A; White-Williams C; Todd B; Ormaza S; Kaan A; Costanzo MR; Piccione W
    Ann Thorac Surg; 2004 Apr; 77(4):1321-7. PubMed ID: 15063260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Destination therapy with left ventricular assist devices: patient selection and outcomes.
    Slaughter MS; Meyer AL; Birks EJ
    Curr Opin Cardiol; 2011 May; 26(3):232-6. PubMed ID: 21430527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The next treatment option: using ventricular assist devices for heart failure.
    Stahovich M; Chillcott S; Dembitsky WP
    Crit Care Nurs Q; 2007; 30(4):337-46. PubMed ID: 17873570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient selection for left ventricular assist devices.
    Lund LH; Matthews J; Aaronson K
    Eur J Heart Fail; 2010 May; 12(5):434-43. PubMed ID: 20172939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptomatic relief: left ventricular assist devices versus resynchronization therapy.
    Delgado RM; Radovancevic B
    Heart Fail Clin; 2007 Jul; 3(3):259-65. PubMed ID: 17723934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications in patients with ventricular assist devices.
    Barnes K
    Dimens Crit Care Nurs; 2008; 27(6):233-41; quiz 242-3. PubMed ID: 18953188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
    Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
    Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricle assist device: when and which patients should we refer?
    Trochu JN; Leprince P; Bielefeld-Gomez M; Bastien O; Beauvais F; Gueffet JP; Logeart D; Isnard R; Iliou MC; Leclercq C; Girard C
    Arch Cardiovasc Dis; 2012 Feb; 105(2):114-21. PubMed ID: 22424329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How does successful bridging with ventricular assist device affect cardiac transplantation outcome?
    Urban M; Pirk J; Dorazilova Z; Netuka I
    Interact Cardiovasc Thorac Surg; 2011 Oct; 13(4):405-9. PubMed ID: 21788304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy.
    Rogers JG; Bostic RR; Tong KB; Adamson R; Russo M; Slaughter MS
    Circ Heart Fail; 2012 Jan; 5(1):10-6. PubMed ID: 22052901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
    McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
    Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular assistance to bridge to transplantation.
    Kherani AR; Oz MC
    Surg Clin North Am; 2004 Feb; 84(1):75-89, viii-ix. PubMed ID: 15053184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacotherapy implications of ventricular assist device in the patient with end-stage heart failure.
    Von Ruden SA; Murray MA; Grice JL; Proebstle AK; Kopacek KJ
    J Pharm Pract; 2012 Apr; 25(2):232-49. PubMed ID: 22392840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.